Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials

Antithrombotic treatment may improve the disease course in non-critically ill, symptomatic COVID-19 outpatients.

Source: Thrombosis Research - August 17, 2023 Category: Hematology Authors: Stefano Barco, Saverio Virdone, Andrea G ötschi, Walter Ageno, Juan I. Arcelus, Roland Bingisser, Giuseppe Colucci, Frank Cools, Daniel Duerschmied, Harry Gibbs, Riccardo M. Fumagalli, Bernhard Gerber, Sylvia Haas, Jelle C.L. Himmelreich, Richard Hobbs, Tags: Full Length Article Source Type: research